data_1j6q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j6q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 130.08 4.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.68 62.04 3.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.836 0.854 . . . . 0.0 111.438 -170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -76.27 62.82 1.82 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.717 -0.614 . . . . 0.0 109.702 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -101.27 162.16 13.1 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 124.019 0.927 . . . . 0.0 110.371 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -91.14 118.52 30.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.53 143.5 51.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.935 1.294 . . . . 0.0 109.148 -173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.34 142.49 78.42 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.913 0.885 . . . . 0.0 110.32 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.73 -46.62 32.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.903 2.402 . . . . 0.0 110.824 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.34 -42.56 14.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 112.695 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -59.01 -56.2 25.3 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.8 pt -79.44 42.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.321 1.048 . . . . 0.0 112.266 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -141.86 -55.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 126.49 1.916 . . . . 0.0 106.291 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -73.17 80.55 1.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.768 -0.583 . . . . 0.0 111.532 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.51 53.81 11.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 170.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -149.52 -107.47 0.07 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.046 2.138 . . . . 0.0 108.312 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.6 m -64.27 -61.76 2.04 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.826 1.651 . . . . 0.0 112.154 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.8 -54.96 1.22 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.683 1.193 . . . . 0.0 110.928 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 -6.51 58.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.506 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.78 40.01 40.52 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.345 1.926 . . . . 0.0 112.757 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.68 -41.35 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 118.392 1.096 . . . . 0.0 112.417 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -102.94 -74.8 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.32 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.96 112.52 3.51 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.539 1.493 . . . . 0.0 110.618 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -67.41 153.75 42.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.41 160.48 10.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.525 0.202 . . . . 0.0 110.581 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.05 76.03 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.507 -0.745 . . . . 0.0 114.306 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.03 148.45 22.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.832 1.316 . . . . 0.0 110.383 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -84.26 139.53 32.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.826 0.285 . . . . 0.0 110.548 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.5 pt -149.37 174.54 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 166.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -118.87 120.94 38.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.01 142.14 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.76 122.13 2.67 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.35 -172.6 38.98 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 21.9 ptp -101.25 133.97 45.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.858 0.863 . . . . 0.0 111.103 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -75.94 119.19 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 111.272 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -60.22 118.64 6.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 p -46.58 -43.85 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.31 1.444 . . . . 0.0 113.054 -170.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.89 61.41 0.39 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -137.24 -4.35 1.9 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpt -69.36 110.21 4.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.39 147.21 28.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.99 146.35 40.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.87 0.868 . . . . 0.0 110.627 -168.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.84 149.78 80.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -65.89 -19.64 58.38 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.213 1.942 . . . . 0.0 110.836 168.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -49.15 -30.94 7.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.234 0.614 . . . . 0.0 109.595 167.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 68.25 30.71 5.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.116 1.366 . . . . 0.0 111.637 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.88 7.0 0.27 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.657 1.583 . . . . 0.0 112.097 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -137.44 127.44 25.86 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.99 139.7 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -170.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.88 154.64 42.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.676 -0.64 . . . . 0.0 109.593 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.22 156.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.85 -171.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.18 48.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.78 134.21 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -132.49 -168.52 2.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.889 0.875 . . . . 0.0 110.313 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -136.26 169.68 17.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.184 1.793 . . . . 0.0 106.416 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 m -53.17 -30.99 40.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.889 0.476 . . . . 0.0 110.173 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.93 -7.66 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.09 73.78 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.059 0.845 . . . . 0.0 113.99 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.96 77.12 0.35 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -67.9 130.75 43.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.882 0.473 . . . . 0.0 110.359 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.03 149.79 15.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 125.212 1.405 . . . . 0.0 107.895 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 128.41 46.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.587 1.155 . . . . 0.0 109.883 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.7 137.55 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.013 1.325 . . . . 0.0 107.921 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -116.87 145.79 43.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.214 1.406 . . . . 0.0 107.949 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 12.0 t80 -145.68 127.46 15.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -117.9 48.25 1.42 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.796 1.238 . . . . 0.0 112.482 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -162.87 -179.6 6.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.468 1.907 . . . . 0.0 105.963 169.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -72.6 123.09 22.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.203 -0.936 . . . . 0.0 110.123 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -59.63 158.26 23.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.284 1.034 . . . . 0.0 109.93 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.37 -92.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.826 3.017 . . . . 0.0 111.608 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.93 43.19 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.713 -1.242 . . . . 0.0 110.129 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.23 13.05 0.1 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.586 1.955 . . . . 0.0 113.839 -167.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 t80 59.52 79.44 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 109.686 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -57.52 116.67 3.51 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -75.88 170.58 15.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.313 0.645 . . . . 0.0 111.451 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.11 47.18 84.37 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -151.41 -179.79 7.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.533 1.533 . . . . 0.0 106.919 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.86 149.39 19.49 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.76 166.4 11.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.42 133.16 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.46 118.38 21.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.896 1.279 . . . . 0.0 109.95 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -114.53 145.49 41.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.108 0.963 . . . . 0.0 109.471 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.42 -125.57 1.02 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 169.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.38 146.56 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -172.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.41 113.36 2.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.77 -99.15 1.92 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.44 78.9 4.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 13.52 67.29 0.01 OUTLIER 'General case' 0 C--N 1.34 0.186 0 C-N-CA 129.63 3.172 . . . . 0.0 113.172 169.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.04 -57.73 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 141.39 32.02 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.769 0.795 . . . . 0.0 110.292 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.2 122.88 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.31 95.51 10.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.79 153.23 19.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.832 0.853 . . . . 0.0 110.493 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.421 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 11.5 t -147.35 -40.32 0.19 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.252 0.621 . . . . 0.0 111.828 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.65 76.34 9.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.3 m -88.47 129.24 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -116.51 111.57 20.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.7 59.66 1.2 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.25 -27.45 67.22 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.848 -0.533 . . . . 0.0 110.14 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 130.08 4.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.68 62.04 3.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.836 0.854 . . . . 0.0 111.438 -170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -76.27 62.82 1.82 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.717 -0.614 . . . . 0.0 109.702 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -101.27 162.16 13.1 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 124.019 0.927 . . . . 0.0 110.371 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -91.14 118.52 30.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.53 143.5 51.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.935 1.294 . . . . 0.0 109.148 -173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.34 142.49 78.42 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.913 0.885 . . . . 0.0 110.32 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.73 -46.62 32.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.903 2.402 . . . . 0.0 110.824 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.34 -42.56 14.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 112.695 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -59.01 -56.2 25.3 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.8 pt -79.44 42.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.321 1.048 . . . . 0.0 112.266 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -141.86 -55.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 126.49 1.916 . . . . 0.0 106.291 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -73.17 80.55 1.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.768 -0.583 . . . . 0.0 111.532 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.51 53.81 11.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 170.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -149.52 -107.47 0.07 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.046 2.138 . . . . 0.0 108.312 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.6 m -64.27 -61.76 2.04 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.826 1.651 . . . . 0.0 112.154 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.8 -54.96 1.22 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.683 1.193 . . . . 0.0 110.928 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 -6.51 58.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.506 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.78 40.01 40.52 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.345 1.926 . . . . 0.0 112.757 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.68 -41.35 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 118.392 1.096 . . . . 0.0 112.417 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -102.94 -74.8 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.32 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.96 112.52 3.51 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.539 1.493 . . . . 0.0 110.618 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -67.41 153.75 42.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.41 160.48 10.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.525 0.202 . . . . 0.0 110.581 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.05 76.03 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.507 -0.745 . . . . 0.0 114.306 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.03 148.45 22.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.832 1.316 . . . . 0.0 110.383 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -84.26 139.53 32.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.826 0.285 . . . . 0.0 110.548 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.5 pt -149.37 174.54 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 166.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -118.87 120.94 38.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.01 142.14 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.76 122.13 2.67 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.35 -172.6 38.98 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 21.9 ptp -101.25 133.97 45.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.858 0.863 . . . . 0.0 111.103 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -75.94 119.19 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 111.272 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -60.22 118.64 6.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 p -46.58 -43.85 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.31 1.444 . . . . 0.0 113.054 -170.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.89 61.41 0.39 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -137.24 -4.35 1.9 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpt -69.36 110.21 4.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.39 147.21 28.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.99 146.35 40.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.87 0.868 . . . . 0.0 110.627 -168.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.84 149.78 80.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -65.89 -19.64 58.38 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.213 1.942 . . . . 0.0 110.836 168.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -49.15 -30.94 7.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.234 0.614 . . . . 0.0 109.595 167.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 68.25 30.71 5.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.116 1.366 . . . . 0.0 111.637 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.88 7.0 0.27 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.657 1.583 . . . . 0.0 112.097 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -137.44 127.44 25.86 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.99 139.7 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -170.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.88 154.64 42.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.676 -0.64 . . . . 0.0 109.593 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.22 156.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.85 -171.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.18 48.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.78 134.21 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -132.49 -168.52 2.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.889 0.875 . . . . 0.0 110.313 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -136.26 169.68 17.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.184 1.793 . . . . 0.0 106.416 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 m -53.17 -30.99 40.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.889 0.476 . . . . 0.0 110.173 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.93 -7.66 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.09 73.78 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.059 0.845 . . . . 0.0 113.99 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.96 77.12 0.35 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -67.9 130.75 43.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.882 0.473 . . . . 0.0 110.359 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.03 149.79 15.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 125.212 1.405 . . . . 0.0 107.895 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 128.41 46.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.587 1.155 . . . . 0.0 109.883 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.7 137.55 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.013 1.325 . . . . 0.0 107.921 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -116.87 145.79 43.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.214 1.406 . . . . 0.0 107.949 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 12.0 t80 -145.68 127.46 15.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -117.9 48.25 1.42 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.796 1.238 . . . . 0.0 112.482 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -162.87 -179.6 6.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.468 1.907 . . . . 0.0 105.963 169.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -72.6 123.09 22.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.203 -0.936 . . . . 0.0 110.123 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -59.63 158.26 23.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.284 1.034 . . . . 0.0 109.93 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.37 -92.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.826 3.017 . . . . 0.0 111.608 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.93 43.19 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.713 -1.242 . . . . 0.0 110.129 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.23 13.05 0.1 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.586 1.955 . . . . 0.0 113.839 -167.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 t80 59.52 79.44 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 109.686 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -57.52 116.67 3.51 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -75.88 170.58 15.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.313 0.645 . . . . 0.0 111.451 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.11 47.18 84.37 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -151.41 -179.79 7.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.533 1.533 . . . . 0.0 106.919 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.86 149.39 19.49 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.76 166.4 11.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.42 133.16 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.46 118.38 21.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.896 1.279 . . . . 0.0 109.95 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -114.53 145.49 41.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.108 0.963 . . . . 0.0 109.471 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.42 -125.57 1.02 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 169.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.38 146.56 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -172.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.41 113.36 2.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.77 -99.15 1.92 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.44 78.9 4.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 13.52 67.29 0.01 OUTLIER 'General case' 0 C--N 1.34 0.186 0 C-N-CA 129.63 3.172 . . . . 0.0 113.172 169.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.04 -57.73 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 141.39 32.02 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.769 0.795 . . . . 0.0 110.292 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.2 122.88 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.31 95.51 10.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.79 153.23 19.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.832 0.853 . . . . 0.0 110.493 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.442 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 11.5 t -147.35 -40.32 0.19 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.252 0.621 . . . . 0.0 111.828 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.65 76.34 9.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.3 m -88.47 129.24 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -116.51 111.57 20.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.7 59.66 1.2 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.25 -27.45 67.22 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.848 -0.533 . . . . 0.0 110.14 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 130.08 4.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.68 62.04 3.12 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.836 0.854 . . . . 0.0 111.438 -170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -76.27 62.82 1.82 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.717 -0.614 . . . . 0.0 109.702 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -101.27 162.16 13.1 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 124.019 0.927 . . . . 0.0 110.371 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -91.14 118.52 30.5 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.485 1.114 . . . . 0.0 108.411 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.53 143.5 51.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.935 1.294 . . . . 0.0 109.148 -173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.34 142.49 78.42 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.913 0.885 . . . . 0.0 110.32 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -54.73 -46.62 32.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.903 2.402 . . . . 0.0 110.824 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.34 -42.56 14.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.216 1.406 . . . . 0.0 112.695 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -59.01 -56.2 25.3 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.8 pt -79.44 42.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.321 1.048 . . . . 0.0 112.266 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.5 t -141.86 -55.16 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 126.49 1.916 . . . . 0.0 106.291 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -73.17 80.55 1.28 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.768 -0.583 . . . . 0.0 111.532 -173.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.51 53.81 11.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 170.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -149.52 -107.47 0.07 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.046 2.138 . . . . 0.0 108.312 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.6 m -64.27 -61.76 2.04 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 125.826 1.651 . . . . 0.0 112.154 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.8 -54.96 1.22 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.683 1.193 . . . . 0.0 110.928 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 -6.51 58.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.506 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 50.78 40.01 40.52 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 126.345 1.926 . . . . 0.0 112.757 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -93.68 -41.35 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 118.392 1.096 . . . . 0.0 112.417 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -102.94 -74.8 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.32 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.96 112.52 3.51 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.539 1.493 . . . . 0.0 110.618 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -67.41 153.75 42.95 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.41 160.48 10.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.525 0.202 . . . . 0.0 110.581 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.3 -1.05 76.03 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.507 -0.745 . . . . 0.0 114.306 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -96.03 148.45 22.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.832 1.316 . . . . 0.0 110.383 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -84.26 139.53 32.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.826 0.285 . . . . 0.0 110.548 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.5 pt -149.37 174.54 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 166.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -118.87 120.94 38.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.01 142.14 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.76 122.13 2.67 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.35 -172.6 38.98 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 21.9 ptp -101.25 133.97 45.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.858 0.863 . . . . 0.0 111.103 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -75.94 119.19 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 111.272 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.8 m -60.22 118.64 6.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 p -46.58 -43.85 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.31 1.444 . . . . 0.0 113.054 -170.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.89 61.41 0.39 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -137.24 -4.35 1.9 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpt -69.36 110.21 4.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.39 147.21 28.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.99 146.35 40.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.87 0.868 . . . . 0.0 110.627 -168.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.84 149.78 80.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -65.89 -19.64 58.38 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.213 1.942 . . . . 0.0 110.836 168.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -49.15 -30.94 7.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.234 0.614 . . . . 0.0 109.595 167.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 68.25 30.71 5.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.116 1.366 . . . . 0.0 111.637 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.88 7.0 0.27 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.657 1.583 . . . . 0.0 112.097 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -137.44 127.44 25.86 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.99 139.7 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 -170.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.88 154.64 42.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.676 -0.64 . . . . 0.0 109.593 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.22 156.57 38.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.85 -171.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.68 132.18 48.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.78 134.21 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -132.49 -168.52 2.07 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.889 0.875 . . . . 0.0 110.313 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -136.26 169.68 17.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.184 1.793 . . . . 0.0 106.416 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 m -53.17 -30.99 40.41 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.889 0.476 . . . . 0.0 110.173 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 49.4 mt -64.93 -7.66 12.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.61 27.09 73.78 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.059 0.845 . . . . 0.0 113.99 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.96 77.12 0.35 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -67.9 130.75 43.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.882 0.473 . . . . 0.0 110.359 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.03 149.79 15.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 125.212 1.405 . . . . 0.0 107.895 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.82 128.41 46.87 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.587 1.155 . . . . 0.0 109.883 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.3 t -115.7 137.55 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.013 1.325 . . . . 0.0 107.921 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -116.87 145.79 43.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.214 1.406 . . . . 0.0 107.949 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 12.0 t80 -145.68 127.46 15.32 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -172.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -117.9 48.25 1.42 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.796 1.238 . . . . 0.0 112.482 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -162.87 -179.6 6.91 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.468 1.907 . . . . 0.0 105.963 169.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -72.6 123.09 22.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.203 -0.936 . . . . 0.0 110.123 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -59.63 158.26 23.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.284 1.034 . . . . 0.0 109.93 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.37 -92.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.826 3.017 . . . . 0.0 111.608 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.93 43.19 0.42 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.713 -1.242 . . . . 0.0 110.129 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.23 13.05 0.1 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.586 1.955 . . . . 0.0 113.839 -167.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.8 t80 59.52 79.44 0.23 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.595 1.158 . . . . 0.0 109.686 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -57.52 116.67 3.51 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -75.88 170.58 15.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.313 0.645 . . . . 0.0 111.451 -174.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.11 47.18 84.37 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -151.41 -179.79 7.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.533 1.533 . . . . 0.0 106.919 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.86 149.39 19.49 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 168.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.76 166.4 11.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.42 133.16 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.46 118.38 21.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.896 1.279 . . . . 0.0 109.95 -170.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -114.53 145.49 41.87 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.108 0.963 . . . . 0.0 109.471 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 177.42 -125.57 1.02 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 169.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -140.38 146.56 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -172.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.41 113.36 2.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.77 -99.15 1.92 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 -173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.44 78.9 4.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 13.52 67.29 0.01 OUTLIER 'General case' 0 C--N 1.34 0.186 0 C-N-CA 129.63 3.172 . . . . 0.0 113.172 169.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.04 -57.73 0.51 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -168.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 141.39 32.02 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.769 0.795 . . . . 0.0 110.292 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.2 122.88 36.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.31 95.51 10.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.79 153.23 19.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.832 0.853 . . . . 0.0 110.493 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.442 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 11.5 t -147.35 -40.32 0.19 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.252 0.621 . . . . 0.0 111.828 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.65 76.34 9.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.3 m -88.47 129.24 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -116.51 111.57 20.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.7 59.66 1.2 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -67.25 -27.45 67.22 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.848 -0.533 . . . . 0.0 110.14 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.62 . . . . . . . . 1 1 . 1 stop_ save_